ESR1 and breast neoplasm: Therefore, the down-regulation of CK6 by 4OHNDtam should be further explored in appropriate designed `bench-to-bed`studies since it may represent a new insight in understanding of the anti-cancer action of this active tamoxifen metabolite in ER positive breast tumors.